A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
Genentech, Inc.
Genentech, Inc.
University of Texas Southwestern Medical Center
Hospices Civils de Lyon
Eli Lilly and Company
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Francisco
University College, London
Tel-Aviv Sourasky Medical Center